Herein, we confirmed the role of the ERRα/p53 complex, which is required to maintain mitochondrial function in colon cancer and targeting ERRα resulted in mitochondrial dysfunction, causing higher cytotoxicity in cells with loss of p53. Here, ESRRA is linked to malignant colon neoplasm.